141 related articles for article (PubMed ID: 37406529)
1. Socio-demographic and cultural factors related to non-participation in the Dutch colorectal cancer screening programme.
van de Schootbrugge-Vandermeer HJ; Lansdorp-Vogelaar I; de Jonge L; van Vuuren AJ; Dekker E; Spaander MCW; Ramakers CRB; Nagtegaal ID; van Kemenade FJ; van Leerdam ME; Toes-Zoutendijk E
Eur J Cancer; 2023 Sep; 190():112942. PubMed ID: 37406529
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic position and participation in colorectal cancer screening.
Frederiksen BL; Jørgensen T; Brasso K; Holten I; Osler M
Br J Cancer; 2010 Nov; 103(10):1496-501. PubMed ID: 20959827
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing.
van der Meulen MP; Toes-Zoutendijk E; Spaander MCW; Dekker E; Bonfrer JMG; van Vuuren AJ; Kuipers EJ; van Kemenade FJ; van Velthuysen MF; Thomeer MGJ; van Veldhuizen H; de Koning HJ; Lansdorp-Vogelaar I; van Leerdam ME
PLoS One; 2022; 17(2):e0264067. PubMed ID: 35176116
[TBL] [Abstract][Full Text] [Related]
4. Reducing income-related inequities in colorectal cancer screening: lessons learned from a retrospective analysis of organised programme and non-programme screening delivery in Winnipeg, Manitoba.
Decker KM; Demers AA; Nugent Z; Biswanger N; Singh H
BMJ Open; 2016 Feb; 6(2):e009470. PubMed ID: 26908517
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of colorectal cancer screening across sociodemographic groups in Denmark: a register-based study.
Pallesen AVJ; Herrstedt J; Westendorp RGJ; Mortensen LH; Kristiansen M
Acta Oncol; 2021 Mar; 60(3):323-332. PubMed ID: 33427545
[TBL] [Abstract][Full Text] [Related]
6. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
7. Differences in diagnostic activity in general practice and findings for individuals invited to the danish screening programme for colorectal cancer: a population-based cohort study.
Juul JS; Andersen B; Laurberg S; Carlsen AH; Olesen F; Vedsted P
Scand J Prim Health Care; 2018 Sep; 36(3):281-290. PubMed ID: 29929415
[TBL] [Abstract][Full Text] [Related]
8. Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study.
Guiriguet C; Pera G; Castells A; Toran P; Grau J; Rivero I; Buron A; Macià F; Vela-Vallespín C; Vilarrubí-Estrella M; Marzo-Castillejo M
BMC Cancer; 2017 Aug; 17(1):524. PubMed ID: 28784093
[TBL] [Abstract][Full Text] [Related]
9. Does the Flemish colorectal cancer screening programme reach equity in FIT uptake?
Hoeck S; van de Veerdonk W; De Brabander I; Kellen E
Eur J Public Health; 2019 Dec; 29(6):1108-1114. PubMed ID: 30887054
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer screening participation among citizens not recommended to be screened: a cohort study.
Larsen PT; Jørgensen SF; Njor SH
BMC Gastroenterol; 2022 May; 22(1):256. PubMed ID: 35596148
[TBL] [Abstract][Full Text] [Related]
11. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
Breekveldt ECH; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Spaander MCW; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; Krul MF; Kok NFM; Kuhlmann KFD; Vink GR; van Leerdam ME; Elferink MAG;
Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):60-68. PubMed ID: 34822762
[TBL] [Abstract][Full Text] [Related]
13. The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.
Kooyker AI; Toes-Zoutendijk E; Opstal-van Winden AWJ; Spaander MCW; Buskermolen M; van Vuuren HJ; Kuipers EJ; van Kemenade FJ; Ramakers C; Thomeer MGJ; Dekker E; Nagtegaal ID; de Koning HJ; van Leerdam ME; Lansdorp-Vogelaar I
Int J Cancer; 2020 Aug; 147(4):1098-1106. PubMed ID: 31853977
[TBL] [Abstract][Full Text] [Related]
14. Are anxiety levels associated with the decision to participate in a Swedish colorectal cancer screening programme? A nationwide cross-sectional study.
Wangmar J; von Vogelsang AC; Hultcrantz R; Fritzell K; Wengström Y; Jervaeus A
BMJ Open; 2018 Dec; 8(12):e025109. PubMed ID: 30580275
[TBL] [Abstract][Full Text] [Related]
15. Assessing knowledge and attitudes towards screening among users of Faecal Immunochemical Test (FIT).
Denters MJ; Deutekom M; Essink-Bot ML; Bossuyt PM; Fockens P; Dekker E
Health Expect; 2015 Oct; 18(5):839-49. PubMed ID: 23432931
[TBL] [Abstract][Full Text] [Related]
16. Sociodemographic features and patterns of non-participation in colorectal cancer screening in Finland.
Jäntti M; Heinävaara S; Malila N; Sarkeala T
Eur J Public Health; 2021 Oct; 31(4):890-894. PubMed ID: 34347069
[TBL] [Abstract][Full Text] [Related]
17. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
[TBL] [Abstract][Full Text] [Related]
18. To do or not to do - a survey study on factors associated with participating in the Danish screening program for colorectal cancer.
Nielsen JB; Berg-Beckhoff G; Leppin A
BMC Health Serv Res; 2021 Jan; 21(1):43. PubMed ID: 33413310
[TBL] [Abstract][Full Text] [Related]
19. What Factors Influence Non-Participation Most in Colorectal Cancer Screening? A Discrete Choice Experiment.
de Bekker-Grob EW; Donkers B; Veldwijk J; Jonker MF; Buis S; Huisman J; Bindels P
Patient; 2021 Mar; 14(2):269-281. PubMed ID: 33150461
[TBL] [Abstract][Full Text] [Related]
20. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
